Chemical Properties:
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.Commercial Supply Ensitrelvir (S-217622) Intermediates: S-Ethylisothiourea Hydrobromide CAS 1071-37-0 2,4,5-Trifluorobenzyl Bromide CAS 157911-56-3 Trimethyloxonium Tetrafluoroborate CAS 420-37-1 6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4 3-(Chloromethyl)-1-methyl-1H-1,2,4-triazole hydrochloride CAS 135206-76-7 1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)- CAS 1360105-53-8Item | Specifications |
Purity | >98.0% |
Loss on Drying | <1.00% |
Total Impurities | <2.00% |
Test Standard | Enterprise Standard |
Usage | Intermediate of Ensitrelvir (S-217622), COVID-19 |
Description:
Specifications:
Package & Storage:
Chemical Name | 1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)- |
Synonyms | 3-tert-butyl-6-(ethylthio)-1,3,5-triazine-2,4(1H,3H)-dione |
CAS Number | 1360105-53-8 |
CAT Number | RF-PI1504 |
Stock Status | In Stock |
Molecular Formula | C9H15N3O2S |
Molecular Weight | 229.3 |
Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
3-(Chloromethyl)-1-methyl-1H-1,2,4-triazole hydrochloride (CAS: 135206-76-7) is an intermediate of Ensitrelvir (S-217622). Ensitrelvir is an antiviral drug developed by Shionogi in partnership with Hokkaido University, which acts as an orally active 3C-like protease inhibitor for the treatment of COVID-19 infection. It is taken by mouth, and has been successfully tested against the recently emerged Omicron variant. It became the first Japanese domestic pill to treat COVID-19, third to be regulatorally approved in Japan; in February 2022.